[{"address1": "3963 Maple Avenue", "address2": "Suite 350", "city": "Dallas", "state": "TX", "zip": "75219", "country": "United States", "phone": "972 499 3350", "website": "https://instilbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bronson  Crouch", "age": 51, "title": "Chairman & CEO", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 1140189, "exercisedValue": 0, "unexercisedValue": 35349}, {"maxAge": 1, "name": "Dr. Sandeep  Laumas M.D.", "age": 55, "title": "CFO & Chief Business Officer", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 741521, "exercisedValue": 0, "unexercisedValue": 61910}, {"maxAge": 1, "name": "Dr. Mark E. Dudley Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 24.01, "open": 24.25, "dayLow": 22.23, "dayHigh": 24.8611, "regularMarketPreviousClose": 24.01, "regularMarketOpen": 24.25, "regularMarketDayLow": 22.23, "regularMarketDayHigh": 24.8611, "payoutRatio": 0.0, "beta": 1.724, "forwardPE": -1.8496273, "volume": 111042, "regularMarketVolume": 111042, "averageVolume": 99227, "averageVolume10days": 95650, "averageDailyVolume10Day": 95650, "bid": 21.8, "ask": 22.82, "bidSize": 1, "askSize": 1, "marketCap": 145690496, "fiftyTwoWeekLow": 9.62, "fiftyTwoWeekHigh": 92.0, "fiftyDayAverage": 22.0723, "twoHundredDayAverage": 23.0552, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 120888544, "profitMargins": 0.0, "floatShares": 2710005, "sharesOutstanding": 6525890, "sharesShort": 696978, "sharesShortPriorMonth": 587920, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.106800005, "heldPercentInsiders": 0.1282, "heldPercentInstitutions": 0.80386, "shortRatio": 6.53, "shortPercentOfFloat": 0.1848, "impliedSharesOutstanding": 6525890, "bookValue": 27.023, "priceToBook": 0.8261481, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -75165000, "trailingEps": -11.56, "forwardEps": -12.07, "lastSplitFactor": "1:20", "lastSplitDate": 1701993600, "enterpriseToEbitda": -2.124, "52WeekChange": 1.0503843, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 22.325, "targetHighPrice": 180.0, "targetLowPrice": 52.0, "targetMeanPrice": 114.0, "targetMedianPrice": 110.0, "recommendationMean": 1.75, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 121143000, "totalCashPerShare": 18.563, "ebitda": -56910000, "totalDebt": 85345000, "quickRatio": 11.784, "currentRatio": 12.896, "debtToEquity": 48.4, "returnOnAssets": -0.12404, "returnOnEquity": -0.36633998, "freeCashflow": -24233376, "operatingCashflow": -58518000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TIL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Instil Bio, Inc.", "longName": "Instil Bio, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "regularMarketChange": -1.6849995, "regularMarketDayRange": "22.23 - 24.8611", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 99227, "fiftyTwoWeekLowChange": 12.705001, "fiftyTwoWeekLowChangePercent": 1.3206862, "fiftyTwoWeekRange": "9.62 - 92.0", "fiftyTwoWeekHighChange": -69.675, "fiftyTwoWeekHighChangePercent": -0.757337, "fiftyTwoWeekChangePercent": 105.03843, "earningsTimestampStart": 1742381940, "earningsTimestampEnd": 1742817600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -11.56, "epsForward": -12.07, "epsCurrentYear": -12.27, "priceEpsCurrentYear": -1.8194784, "fiftyDayAverageChange": 0.2527008, "fiftyDayAverageChangePercent": 0.011448775, "twoHundredDayAverageChange": -0.7301998, "twoHundredDayAverageChangePercent": -0.031671803, "marketState": "REGULAR", "regularMarketChangePercent": -7.0179067, "regularMarketPrice": 22.325, "regularMarketTime": 1740171006, "corporateActions": [], "exchange": "NCM", "messageBoardId": "finmb_638929728", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "averageAnalystRating": "1.8 - Buy", "cryptoTradeable": false, "displayName": "Instil Bio", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]